New Products

DALLAS — U by Kotex, a feminine care brand by Kimberly-Clark, has introduced U by Kotex Extra pads — a new maxi pad designed to provide maximum, heavy-duty protection.

The brand's most absorbent pad yet, U by Kotex Extra pads is inviting girls to put it to the test in their own "real life product demos" and experience firsthand how it performs. Girls can receive a free U by Kotex Extra pad sample at ubykotex.com and share the results of their "real life demos" using #demodiaries. 

ST. SIMONS ISLAND, Ga. — Available now nationally at Walmart and other select grocery retailers, Farm Rich announced today three new snacks to the company's portfolio.

TORONTO — Bouche Baby Inc. announced today the commercial release of its new baby-to-toddler feeding system, which includes the Take 'N Shake Feeding Bottle with Integrated Formula Compartment.

 SPARTANBURG, S.C. — Emdeon has given pharmacy automation products maker QS/1 certification for electronic prescriptions of controlled substances, or EPCS, QS/1 said Thursday.

RICHMOND HILL, Ontario — A new app allows patients to communicate through audio and video with their pharmacies using a smartphone, tablet or computer.

Face to FaceRx announced the launch of its Prescriptions Mobile App, which also allows patients to send the prescriptions directly to a call center where it will be input directly into the pharmacy's system for immediate dispensing.

PHOENIX — Natural snack food brand Boulder Canyon announced this week new Baked Sweet Potato Fries, a completely natural snack that mirrors the shape, taste and texture of the side dish found in restaurants across the country.

ALLEGAN, Mich. — The Food and Drug Administration has approved a Perrigo generic drug for treating dermatitis, the company said Wednesday.

Perrigo announced the FDA approval of fluticasone propionate lotion in the 0.05% strength. The drug is a generic version of Fougera Pharmaceuticals division PharmaDerm's Cutivate and is used to treat inflammatory and pruritic manifestations of atopic dermatitis in patients ages 1 year and older.

The drug has annual sales of about $19 million, according to Symphony Health Solutions.

BALTIMORE — The Food and Drug Administration has given Lupin Pharmaceuticals tentative approval to two of its products, the company said Wednesday.

Lupin announced the tentative approvals for armodafinil tablets in the 50-mg, 100-mg, 150-mg, 200-mg and 250-mg strengths and doxycycline capsules in the 40-mg strength. Tentative approval means that the drugs meet the FDA's conditions for approval, but can't be marketed yet due to patent or market exclusivity protection that has yet to expire.